Diagnosed with a rare childhood cancer discovered just in time, surgery, proton therapy and chemotherapy saved two-year-old Ava. Though she had to relearn many skills, she is now thriving, with very ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and ...

Investigators in the Clinical Research Division’s Program in Immunology are also members of the cross-divisional Immunotherapy Integrated Research Center (IIRC). Together, they are focused on learning ...

Clinical Laboratory Improvement Amendments, or CLIA, are a high bar as set by the US Government under Clinical Laboratory Improvement Amendment 42 CFR 493.1253 to obtain and maintain quality ...

The fifth Symposium on Infectious Disease in the Immunocompromised Host convened in Seattle last month. Experts and rising ...

IDS Key Areas of Research. Our physicians and scientists apply their extensive experience in immunocompetent and immunocompromised populations to study the epidemiology of infectious diseases, ...

At the Fred Hutch Brain and Spine Metastases Clinic, we specialize in treating patients with a primary cancer that has spread to the brain and spine, known as brain and spine metastases, as well as ...

Fred Hutch scientists conduct research on and develop therapies for many cancers — including blood cancers and solid tumors — as well as for HIV and other nonmalignant diseases. Our scientists study ...

At Fred Hutchinson Cancer Center, we surround you with experts who focus completely on cancer, day in and day out. A handful of people form the core of your care team. You have an oncologist who ...

Fred Hutch’s Immunotherapy Integrated Research Center (IIRC) is dedicated to developing the next generation of immunotherapies for cancer and other diseases. Dozens of faculty members collaborate via ...